Globus Medical, Inc.
GMED
$52.64
$0.010.02%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.26% | 60.62% | 102.10% | 103.89% | 77.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.26% | 60.62% | 102.10% | 103.89% | 77.59% |
| Cost of Revenue | 35.13% | 65.44% | 131.17% | 161.94% | 122.39% |
| Gross Profit | 30.89% | 58.40% | 90.33% | 83.67% | 62.05% |
| SG&A Expenses | 27.16% | 51.92% | 87.47% | 89.34% | 68.91% |
| Depreciation & Amortization | 55.70% | 133.92% | 328.90% | 463.29% | 326.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.63% | 58.16% | 110.73% | 124.12% | 95.92% |
| Operating Income | 58.49% | 73.33% | 66.18% | 34.56% | 16.07% |
| Income Before Tax | 148.76% | -27.01% | -40.23% | -74.54% | -63.61% |
| Income Tax Expenses | 75.38% | -58.28% | -33.79% | -54.69% | -51.84% |
| Earnings from Continuing Operations | 178.51% | -16.19% | -42.05% | -80.09% | -66.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 178.51% | -16.19% | -42.05% | -80.09% | -66.89% |
| EBIT | 58.49% | 73.33% | 66.18% | 34.56% | 16.07% |
| EBITDA | 53.43% | 74.16% | 98.70% | 76.14% | 48.25% |
| EPS Basic | 112.87% | -35.88% | -57.22% | -85.30% | -68.13% |
| Normalized Basic EPS | 29.59% | 14.24% | 14.09% | -8.32% | -8.56% |
| EPS Diluted | 112.66% | -35.72% | -57.31% | -85.57% | -68.02% |
| Normalized Diluted EPS | 28.45% | 14.21% | 14.85% | -7.51% | -7.57% |
| Average Basic Shares Outstanding | 11.73% | 20.09% | 31.36% | 30.40% | 21.61% |
| Average Diluted Shares Outstanding | 12.84% | 20.05% | 30.37% | 29.19% | 20.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |